Pin Therapeutics is Drug Discovery in South Korea that focus on cardiovascular indications business. Founded in 2017. They cover business area such as developer, therapeutic product, chemical biology-drive protein degradation, compound, oncology, neurodegenerative disease, cardiovascular indication, disease-agnostic approach, client, their technology, efficiency, biological specificity, target degradation, recruitment, unique ubiquitin.
2017
( 7 years old in 2024 )
Cardiovascular Indications
-
110 Teheran-ro, 9th floor
Gangnam-gu
Seoul
South Korea
Private
developertherapeutic productchemical biology-drive protein degradationcompoundoncologyneurodegenerative diseasecardiovascular indicationdisease-agnostic approachclienttheir technologyefficiencybiological specificitytarget degradationrecruitmentunique ubiquitin
* We use standard office opening hours in near Pin Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Pin Therapeutics is Drug Discovery business from South Korea that founded in 2017 (7 years old in 2024), Pin Therapeutics business is focusing on Cardiovascular Indications.
Pin Therapeutics headquarter office and corporate office address is located in 110 Teheran-ro, 9th floor Gangnam-gu Seoul South Korea.
Pin Therapeutics was founded in South Korea.
In 2024, Pin Therapeutics is currently focus on cardiovascular indications sector.
Above is snippet of Google Trends for "cardiovascular indications" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Pin Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.